UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Anatomic Region of Cutaneous Melanoma Impacts Survival and Clinical Outcomes: A Population-Based Analysis

Cancers, 2023-02, Vol.15 (4), p.1229

2023

Volltextzugriff (PDF)

The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020

Cancers, 2020-06, Vol.12 (6), p.1543

2020

Volltextzugriff (PDF)

The Inconsistent Assessment of Quality of Life in Patients Treated for Head and Neck Cancer with Anti-EGFR Inhibitors: A Systematic Scoping Review

Cancers, 2023-04, Vol.15 (9), p.2475

2023

Volltextzugriff (PDF)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Cell reports. Medicine, 2021-10, Vol.2 (10), p.100426-100426, Article 100426

2021

Volltextzugriff (PDF)

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2022-04, Vol.28 (7), p.1345-1352

2022

Volltextzugriff (PDF)

Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival

Cancer, 2018-08, Vol.124 (15), p.3181-3191

2018

Volltextzugriff (PDF)

Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer

Otolaryngology-head and neck surgery, 2018-04, Vol.158 (4), p.649-659

2018

Volltextzugriff (PDF)

Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer

JAMA otolaryngology-- head & neck surgery, 2020-12, Vol.146 (12), p.1109

2020

Volltextzugriff (PDF)

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance

Oral oncology, 2024-08, Vol.155, p.106874, Article 106874

2024

Volltextzugriff (PDF)

HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery

Head & neck, 2016-01, Vol.38 (1), p.59-65

2016

Volltextzugriff (PDF)

Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis

Endocrine, 2021-04, Vol.72 (1), p.27-39

2021

Volltextzugriff (PDF)

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation

Otolaryngology-head and neck surgery, 2021-10, Vol.165 (4), p.536-549

2021

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis

Targeted oncology, 2021-11, Vol.16 (6), p.743-752

2021

Volltextzugriff (PDF)

Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions

JCO oncology practice, 2021-01, Vol.17 (1), p.54-56

2021

Volltextzugriff (PDF)

Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer

JCO oncology practice, 2020-12, Vol.16 (12), p.e1417-e1432

2020

Volltextzugriff (PDF)

Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer

JCO oncology practice, 2021-10, Vol.17 (10), p.e1512-e1523

2021

Volltextzugriff (PDF)

Evaluation of ICI sensitivity for pembrolizumab in combination with anti-platelet therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6041-6041

2023

Volltextzugriff (PDF)

Safety and efficacy of immune checkpoint inhibitor (ICI) naïve cohort from study of PDS0101 and pembrolizumab in HPV16-positive head and neck squamous cell carcinoma (HNSCC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6012-6012

2023

Volltextzugriff (PDF)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2574-2574

2019

Volltextzugriff (PDF)

Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6005-6005

2023

Volltextzugriff (PDF)

A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2513-2513

2022

Volltextzugriff (PDF)

A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: Poor-prognosis subgroup analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9548-9548

2023

Volltextzugriff (PDF)

Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post adjuvant PD-1 analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9501-9501

2023

Volltextzugriff (PDF)

Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6006-6006

2021

Volltextzugriff (PDF)

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9515-9515

2021

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(10)
Oncology
(10)
Aged
(6)
Male
(6)
Middle Aged
(6)
Cancer
(5)
Female
(5)
Head And Neck Cancer
(5)
Otorhinolaryngology
(5)
Patients
(5)
Surgery
(5)
Head And Neck Neoplasms - Therapy
(4)
Review
(4)
Squamous Cell Carcinoma
(4)
Squamous Cell Carcinoma Of Head And Neck - Therapy
(4)
Adult
(3)
Cancer Therapies
(3)
Head & Neck Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anatomic Region of Cutaneous Melanoma Impacts Survival and Clinical Outcomes: A Population-Based Analysis

The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020

The Inconsistent Assessment of Quality of Life in Patients Treated for Head and Neck Cancer with Anti-EGFR Inhibitors: A Systematic Scoping Review

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival

Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer

Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance

HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery

Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation

Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis

Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions

Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer

Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer

Evaluation of ICI sensitivity for pembrolizumab in combination with anti-platelet therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC)

Safety and efficacy of immune checkpoint inhibitor (ICI) naïve cohort from study of PDS0101 and pembrolizumab in HPV16-positive head and neck squamous cell carcinoma (HNSCC)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma

A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors

A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: Poor-prognosis subgroup analysis

Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post adjuvant PD-1 analysis

Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC)

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma

Suchergebnisse filtern